These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 370042)

  • 1. Fenfluramine, vitamin C and weight loss.
    Wilson CW; Foran K; Innes JA; Watson ML; Ford MJ; Stoddart ME; Munro JF
    Int J Obes; 1978; 2(4):463-5. PubMed ID: 370042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin C and the anti-obesity effect of fenfluramine.
    Odumosu A; Wilson CW
    Int J Vitam Nutr Res; 1979; 49(3):251-63. PubMed ID: 528154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical observations on the treatment of obese patients with dexfenfluramine].
    Cairella M; Pisculli M; Petraroli AR; Riganelli S; Saracino A; Siani V
    Clin Ter; 1990 Jun; 133(5):289-97. PubMed ID: 2143712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin C and weight reducing drugs on brain ascorbic acid in guinea pigs.
    Odumosu A
    Acta Vitaminol Enzymol; 1981; 3(2):96-102. PubMed ID: 7325103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of fenfluramine on the weekly curve of weight loss during obesity].
    Cabezas Cerrato J; Gómez Pérez M; Marco-Mur AL; Camarero E; Fernández-Cruz A
    Rev Clin Esp; 1974 Jan; 132(1):47-52. PubMed ID: 4840227
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue ascorbic acid, fenfluramine, and changes in fat metabolism.
    Odumosu A; Wilson CW
    Int J Obes; 1979; 3(2):123-31. PubMed ID: 528124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of fenfluramine--a double-blind study.
    Petrie JC; Mowat JA; Bewsher PD; Stowers JM
    Postgrad Med J; 1975; 51 Suppl 1():139-44. PubMed ID: 768954
    [No Abstract]   [Full Text] [Related]  

  • 9. Body weight evolution during dexfenfluramine treatment after initial weight control.
    Finer N
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S25-9. PubMed ID: 1338319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with fenfluramine in obese subjects.
    Sensi S; Della Loggia F; Del Ponte A; Guagnano MT
    Int J Clin Pharmacol Res; 1985; 5(4):247-53. PubMed ID: 4055167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow up.
    O'Connor HT; Richman RM; Steinbeck KS; Caterson ID
    Int J Obes Relat Metab Disord; 1995 Mar; 19(3):181-9. PubMed ID: 7780494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in dietary intake of obese patients treated by diet associated with d-fenfluramine].
    Cairella M; Cairella G; Graziani P; Mirante MG; Taghva AR
    Clin Ter; 1992 Mar; 140(3):235-8. PubMed ID: 1568366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic effects, and the composition of the tissue lost, in weight reduction by obese patients on treatment with fenfluramine.
    Durnin JV; Womersley J
    Br J Pharmacol; 1973 Sep; 49(1):115-20. PubMed ID: 4595485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of fenfluramine in treatment of obesity.
    Douglas JG; Gough J; Preston PG; Frazer I; Haslett C; Chalmers SR; Munro JF
    Lancet; 1983 Feb; 1(8321):384-6. PubMed ID: 6130379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of fenfluramine in obese subjects. Relation between dosage, plasma concentration of the drug and its effect on weight loss].
    Magnoni V; Boni S; Bonini LM; Zecca L; Bareggi SR
    Minerva Med; 1982 Jun; 73(24):1703-10. PubMed ID: 7088388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of obesity with fenfluramine (Ponderal) in general practice].
    Schiøttz-Christensen E
    Ugeskr Laeger; 1979 Sep; 141(39):2660-2. PubMed ID: 394442
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of obesity with fenfluramine (Ponderal)].
    Persson I; Andersen UD; Deckert T
    Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulatory effects of fenfluramine in obese hypertensive patients.
    Mroczek WJ; Lee WR; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1197-202. PubMed ID: 4214654
    [No Abstract]   [Full Text] [Related]  

  • 19. Dexfenfluramine as adjuvant to a low-calorie formula diet in the treatment of obesity: a randomized clinical trial.
    Andersen T; Astrup A; Quaade F
    Int J Obes Relat Metab Disord; 1992 Jan; 16(1):35-40. PubMed ID: 1314242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged weight loss with dexfenfluramine treatment in obese patients.
    Finer N; Craddock D; Lavielle R; Keen H
    Diabete Metab; 1987; 13(6):598-602. PubMed ID: 3329122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.